STELLIAM INVESTMENT MANAGEMENT, LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 27 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STELLIAM INVESTMENT MANAGEMENT, LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$16,265,000
-46.1%
11,500,000
-57.0%
0.54%
-46.5%
Q3 2016$30,177,000
+7.0%
26,750,000
+4.9%
1.01%
+3.5%
Q2 2016$28,209,000
+79.0%
25,500,000
+75.9%
0.98%
+100.0%
Q1 2016$15,760,00014,500,0000.49%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Birch Grove Capital LP 17,250,000$19,146,00010.07%
STELLIAM INVESTMENT MANAGEMENT, LP 25,500,000$28,209,0000.98%
STEELHEAD PARTNERS LLC 6,000,000$6,660,0000.69%
BASSO CAPITAL MANAGEMENT, L.P. 3,695,000$4,097,0000.64%
Bruce & Co., Inc. 2,000,000$2,200,0000.56%
Sonora Investment Management, LLC 1,525,000$1,686,391,0000.39%
Castle Creek Arbitrage, LLC 3,721,000$4,122,0000.34%
WOLVERINE ASSET MANAGEMENT LLC 18,385,000$20,380,0000.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,500,000$7,161,0000.28%
MIZUHO SECURITIES USA LLC 1,600,000$1,766,0000.28%
View complete list of AMAG PHARMACEUTICALS INC shareholders